Moody National Bank Trust Division Has $2.70 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Moody National Bank Trust Division reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 18.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 16,252 shares of the biotechnology company’s stock after selling 3,750 shares during the period. Moody National Bank Trust Division’s holdings in Axon Enterprise were worth $2,697,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in AXON. IFP Advisors Inc grew its stake in shares of Axon Enterprise by 36.8% during the third quarter. IFP Advisors Inc now owns 364 shares of the biotechnology company’s stock worth $28,000 after purchasing an additional 98 shares during the period. SJS Investment Consulting Inc. acquired a new stake in shares of Axon Enterprise during the third quarter worth $30,000. Accurate Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $49,000. Covestor Ltd grew its stake in shares of Axon Enterprise by 1,125.7% during the first quarter. Covestor Ltd now owns 429 shares of the biotechnology company’s stock worth $59,000 after purchasing an additional 394 shares during the period. Finally, Signaturefd LLC grew its stake in shares of Axon Enterprise by 27.8% during the third quarter. Signaturefd LLC now owns 598 shares of the biotechnology company’s stock worth $69,000 after purchasing an additional 130 shares during the period. 75.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of analyst reports. JPMorgan Chase & Co. cut Axon Enterprise from an “overweight” rating to a “neutral” rating and set a $224.00 price objective for the company. in a research note on Thursday, March 2nd. Craig Hallum lifted their target price on Axon Enterprise from $215.00 to $242.00 in a report on Wednesday, March 1st. Morgan Stanley lifted their target price on Axon Enterprise from $130.00 to $155.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 13th. JMP Securities lifted their target price on Axon Enterprise from $195.00 to $235.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 1st. Finally, The Goldman Sachs Group initiated coverage on Axon Enterprise in a report on Tuesday, March 7th. They set a “buy” rating and a $263.00 target price on the stock. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $221.64.

Axon Enterprise Stock Down 1.8 %

Shares of NASDAQ:AXON traded down $3.86 during midday trading on Friday, reaching $213.12. The company had a trading volume of 941,629 shares, compared to its average volume of 813,364. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.53. The business’s 50 day moving average price is $196.30 and its 200 day moving average price is $166.30. The stock has a market cap of $15.53 billion, a PE ratio of 104.47 and a beta of 0.92. Axon Enterprise, Inc. has a 1-year low of $82.49 and a 1-year high of $226.00.

Insider Activity at Axon Enterprise

In related news, Director Mark W. Kroll sold 3,549 shares of Axon Enterprise stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $220.73, for a total value of $783,370.77. Following the sale, the director now owns 10,142 shares of the company’s stock, valued at $2,238,643.66. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Mark W. Kroll sold 3,549 shares of Axon Enterprise stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $220.73, for a total value of $783,370.77. Following the sale, the director now owns 10,142 shares of the company’s stock, valued at $2,238,643.66. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 71,499 shares of the business’s stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $185.77, for a total value of $13,282,369.23. Following the transaction, the chief executive officer now directly owns 2,254,734 shares in the company, valued at approximately $418,861,935.18. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 346,891 shares of company stock valued at $65,526,959. 6.90% of the stock is owned by insiders.

Axon Enterprise Profile

(Get Rating)

Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.